Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
About this trial
This trial is enrolling individuals with traumatic spinal cord injuries (at least 3 months since injury) to test the effect of a drug (brivaracetam) on neuropathic pain. If included, participants will receive either: 1) 50mg brivaracetam twice a day for 2 weeks, followed by 50mg three times a day for 2 weeks, followed by 100mg twice a day for 48 days, as tolerated; or 2) placebo drug. Final pain testing will be performed after 3 months.
Included participants
Traumatic
What’s involved
Type
Details
- Participants will receive either 1) 50mg brivaracetam twice a day for 2 weeks, followed by 50mg three times a day for 2 weeks, followed by 100mg twice a day for 48 days, as tolerated or 2) placebo drug.- - Final pain testing will be performed after 3 months.
Potential benefits
Main benefits
Pain
Additional benefits
General health
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Recruiting
- Trial start date
- 1 Jan 2023
- Organisation
- University of Minnesota
- Trial recruitment status
- Recruiting
- Trial start date
- 1 Jan 2023
- Organisation
- University of Minnesota
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more